"The value of integrating the BMT service line with cell therapy researchers, labs and biobanks is essential to an enterprise seeking to maximize treatment effectiveness and research investment," said Hank Wu, director of translational informatics at Remedy Informatics. "The combination of ComprehensiveBMT and InvestigateCT facilitates multidirectional flow of data, beginning at the patient's initial admission and evaluation and continuing throughout and after the transplantation procedure, allowing researchers to analyze the entire longitudinal view for new findings that can improve outcomes for current and future patients. This is a tangible way to realize the promise of personalized medicine.""The traditional data process largely fails to use data from one patient to benefit the next, or to utilize clinical data to inform laboratory research and vice versa," said Dewey. "One of our goals is to introduce a new, fully integrated data paradigm for BMT centers and cell therapy labs around the world."
Remedy Informatics First And Only Vendor Authorized To Submit Full Suite Of AGNIS-Supported CIBMTR Forms, Launches "Live In Five" Software Deployment Program
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts